SFSIG
ABBV icon

San Francisco Sentry Investment Group’s AbbVie ABBV Stock Holding History

San Francisco Sentry Investment Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$500K Buy
4,444
+211
+5% +$23.8K 0.26% 109
2021
Q1 		$458K Buy
4,233
+625
+17% +$66.9K 0.2% 137
2020
Q4 		$387K Sell
3,608
-134
-4% -$12.9K 0.18% 134
2020
Q3 		$328K Buy
3,742
+10
+0.3% +$941 0.17% 141
2020
Q2 		$366K Sell
3,732
-394
-10% -$34.7K 0.19% 117
2020
Q1 		$314K Sell
4,126
-1,105
-21% -$94.1K 0.2% 106
2019
Q4 		$463K Sell
5,231
-466
-8% -$38.7K 0.21% 117
2019
Q3 		$431K Buy
5,697
+755
+15% +$51.8K 0.2% 122
2019
Q2 		$360K Sell
4,942
-129
-3% -$10.1K 0.17% 139
2019
Q1 		$409K Buy
5,071
+175
+4% +$14.3K 0.18% 133
2018
Q4 		$452K Sell
4,896
-4
-0.1% -$352 0.21% 100
2018
Q3 		$463K Buy
4,900
+202
+4% +$19.2K 0.17% 120
2018
Q2 		$435K Buy
4,698
+1,185
+34% +$116K 0.18% 114
2018
Q1 		$332K Buy
3,513
+127
+4% +$14K 0.1% 198
2017
Q4 		$327K Buy
3,386
+450
+15% +$42.4K 0.1% 194
2017
Q3 		$261K Buy
2,936
+277
+10% +$21.1K 0.09% 213
2017
Q2 		$193K Buy
+2,659
New +$179K 0.07% 228
2014
Q4 		– Sell
-1,511
Closed -$87K – 157
2014
Q3 		$87K Buy
1,511
+431
+40% +$23.9K 0.04% 237
2014
Q2 		$61K Buy
1,080
+1,030
+2,060% +$54K 0.03% 288
2014
Q1 		$3K Hold
50
– – ﹤0.01% 618
2013
Q4 		$3K Hold
50
– – ﹤0.01% 594
2013
Q3 		$2K Hold
50
– – ﹤0.01% 603
2013
Q2 		$2K Buy
+50
New +$2.19K ﹤0.01% 611

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

San Francisco Sentry Investment Group's ABBV Position: Q2 2021 in Review

San Francisco Sentry Investment Group increased its AbbVie (ABBV) stake by 5% in Q2 2021, buying an estimated $23.8K and bringing the position to 4,444 shares worth $500K. The position accounts for 0.26% of the portfolio, ranked #109.

San Francisco Sentry Investment Group first reported a position in ABBV in Q2 2013 and has held it in 23 quarters since. 2,676 funds tracked by Wall St. Rank hold ABBV as of Q2 2021.

  • San Francisco Sentry Investment Group held 4,444 shares of AbbVie worth $500K as of Q2 2021.
  • San Francisco Sentry Investment Group bought 211 AbbVie shares in Q2 2021, an estimated $23.8K.
  • AbbVie made up 0.26% of San Francisco Sentry Investment Group's portfolio in Q2 2021, its #109 holding.
  • San Francisco Sentry Investment Group first reported a position in AbbVie in Q2 2013 and has held it in 23 quarters since.
  • 2,676 funds tracked by Wall St. Rank held AbbVie as of Q2 2021.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2021, filed 2 Aug 2021.